All In MedTech

Device Trial Radar · NCT04902248

OTSC vs. Angiographic Embolization in Patients With Refractory Non-variceal Upper Gastrointestinal Bleeding

Endoscopic Application of Over-the-scope Clips (OTSC) vs. Angiographic Embolization in Patients With Refractory Non-variceal Upper Gastrointestinal Bleeding: a Multicenter Randomized Comparison

Last checked: Nov 19, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 236 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

236

Planned (sponsor's estimate)

Start

Nov 27, 2021

Primary completion

Sep 30, 2026

Study completion Nov 30, 2026

Sponsor

Lead sponsor
Chinese University of Hong KongAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 26, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

In the management of patients with acute upper non-variceal upper gastrointestinal bleeding, further bleeding is the most important adverse factor predictive of mortality. In the United Kingdom Audit on acute upper gastrointestinal bleeding, clinical evidence of further bleeding was reported in 13% of patients following the first endoscopy and 27% of them died. The use of OTSC has emerged as an alternative before angiographic embolization(TAE) which is often considered most definitive. We propose to define the algorithm in the management of patients with refractory bleeding from their peptic ulcers or other non variceal causes. We hypothesize that endoscopic use of OTSC compares favourably with TAE and both lead to similar outcomes. An equivalence of the two modalities may mean that endoscopic application of OTSC should be attempted before TAE as often we need to document further bleeds with endoscopy and a second treatment should be instituted at the same time.

Conditions

  • Upper Gastrointestinal Bleeding

Interventions

  • The OTSC® System SetDevice

    The endoscope was extracted and equipped with the OTSC system. OTSC system is deployed on the lesion with suction to target lesion

  • angiographic embolizationProcedure

    Transcatheter selective embolization to bleeding arteries

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. further bleedingTime frame: within 30 days after randomization

Locations

5 sites in 3 countries. Site status is shown where the registry gives one.

  • Beijing friendship Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • the First Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, China · Recruiting

  • Huaxi Hospital of Sichuan University

    Chengdu, Sichuan, China · Recruiting

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.